Medicenna Therapeutics Corp. ("Medicenna" or the "Company") , a clinical-stage immunotherapy company focused on the development of Superkines, announces that Mr. Richard Sutin and Mr. Angelos ...
ATRX, a gene involved in organising and maintaining DNA structure within cells, is commonly altered in neuroblastoma. While the presence of ATRX mutations has long been associated with certain disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results